A long-run study looking into leading Firebrick Pharma (ASX:FRE) product Nasodine has suggested the nasal spray can be an ...

EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Mosanna Therapeutics ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland, is developing ...

Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea (OSA), today announced the close of $80 million in Series A funding. The company is developing an easy-to-use ...